Leading Pharmaceutical Regulatory Lawyer Joins Latham’s Healthcare & Life Sciences Practice in Washington, D.C.

COVID-19 Spurs New Mass Tort Litigation

WASHINGTON, March 29, 2021 / PRNewswire / – Latham & Watkins LLP1 is pleased to announce this Christopher H. Schott has joined the company Washington, DC Office as a partner in the corporate department and member of the practice for health care and life sciences. Schott is a leading doctor in drug price reporting and regularly advises pharmaceutical clients on a variety of health, compliance and regulatory issues, particularly those related to Medicaid, Medicare and 340B Drug pricing programs.

“Chris is a highly respected drug regulatory lawyer and his arrival underscores the firm’s commitment to our world-class healthcare and life sciences practice,” he said John Manthei, Global Chairman of the Latham Healthcare & Life Sciences Practice. “As clients make changes to a number of federal programs, policy debates over drug pricing and value-based approaches, and the accelerating pace of scientific discovery, Chris’ in-depth experience will be of great value. We are excited to join our reimbursement and regulation team for the Health care and further strengthens our capabilities. “

Schott has extensive experience advising pharmaceutical manufacturers on price reporting and other compliance obligations under Medicaid, Medicare and 340B Drug pricing programs that include support for the entire product lifecycle, from pre-launch considerations to commercialization and contract strategies, to decisions about authorized generics and line extensions. He also regularly advises clients on pricing method audits and interactions with federal regulators. Schott draws on its regulatory expertise and understanding of the industry to support a range of corporate transactions in the pharmaceuticals space, including acquisitions and divestitures, as well as licensing and co-promotion agreements.

“Chris will be a great addition to ours Washington, DC Office “said Daniel Lennon, Office Managing Partner of the company Washington, DC Office. “Here in the capital of the country, we combine classic process and regulatory practices with our leading transactional practices. With his extensive regulatory background, industry knowledge and transactional experience, Chris will be a perfect addition to the team and an asset to clients around the world as they try To do business in the US. “

“Latham is known for his regulatory work in healthcare and the life sciences, and I am delighted to be one of these world-class practitioners,” said Schott. “The company’s integrated global platform and dynamic team-oriented approach provide a powerful foundation for supporting my clients, not only in the evolving drug pricing environment but more generally. I look forward to contributing to the continued success of Healthcare & Life Science Practice. ”

Schott comes to Latham from Hogan Lovells Washington, DC He earned his JD with high accolades from The George Washington University Law School and his BA from the University of Maryland.

About Latham & Watkins (lw.com)

Latham & Watkins provides innovative solutions to complex legal and business challenges around the world. From a global platform, our lawyers advise clients on market-shaping transactions, legal disputes and litigation with a high level of commitment as well as on demanding regulatory issues. Latham is one of the world’s largest providers of pro bono services, steadfastly supporting initiatives to promote diversity within the law firm and the legal profession, and is committed to researching and promoting environmental sustainability.

Notes for editors

1 Latham & Watkins operates worldwide as a limited partnership established under the laws of State of Delaware (USA)) with affiliated limited partnerships that practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership that puts the practice in Japan. Latham & Watkins operates in South Korea as a foreign legal advisor office. Latham & Watkins works with the law firm of Salman M. Al-Sudairi by doing Kingdom of Saudi Arabia.


John Manthei, Global Chair, Healthcare & Life Sciences Practice, +1.202.637.2211
Daniel Lennon, Washington, DC Office Managing Partner, +1.202.637.2347

SOURCE Latham & Watkins

similar links